Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(1.86)
# 3,328
Out of 5,081 analysts
340
Total ratings
30.3%
Success rate
-7.96%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACRV Acrivon Therapeutics | Reiterates: Buy | $19 | $2.28 | +733.33% | 13 | Nov 25, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $52 → $51 | $43.76 | +16.54% | 13 | Nov 24, 2025 | |
| AGIO Agios Pharmaceuticals | Maintains: Buy | $56 → $48 | $27.49 | +74.61% | 3 | Nov 20, 2025 | |
| OLMA Olema Pharmaceuticals | Maintains: Buy | $28 → $36 | $27.25 | +32.11% | 22 | Nov 18, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Buy | $12 → $15 | $3.58 | +318.99% | 2 | Nov 12, 2025 | |
| SANA Sana Biotechnology | Maintains: Buy | $11 → $9 | $4.47 | +101.34% | 12 | Nov 7, 2025 | |
| CNTX Context Therapeutics | Maintains: Buy | $4 → $5 | $1.09 | +358.72% | 13 | Nov 6, 2025 | |
| VTYX Ventyx Biosciences | Upgrades: Buy | $18 | $7.84 | +129.59% | 16 | Nov 5, 2025 | |
| NVCR NovoCure | Maintains: Buy | $38 → $42 | $11.81 | +255.63% | 19 | Oct 30, 2025 | |
| RCUS Arcus Biosciences | Maintains: Buy | $24 → $28 | $25.63 | +9.25% | 6 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $72 | $32.06 | +124.61% | 3 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $2.20 | +445.45% | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $60 | $31.61 | +89.81% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.64 | - | 14 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $4.17 | +451.56% | 20 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $40 | $12.64 | +216.46% | 15 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $35 | $10.93 | +220.22% | 14 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $25.86 | +39.21% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $0.89 | +800.09% | 25 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $9 | $3.71 | +142.78% | 2 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $20 | $1.65 | +1,112.12% | 10 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $12.04 | +199.13% | 9 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $72.94 | +57.66% | 13 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $560 → $280 | $8.41 | +3,229.37% | 17 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.65 | +201.89% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.65 | +545.16% | 7 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.78 | +911.24% | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $183 | $3.96 | +4,517.19% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.74 | +847.87% | 14 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.27 | - | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.33 | +1,253.38% | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $0.78 | +4,105.43% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.54 | - | 1 | Apr 25, 2024 |
Acrivon Therapeutics
Nov 25, 2025
Reiterates: Buy
Price Target: $19
Current: $2.28
Upside: +733.33%
AnaptysBio
Nov 24, 2025
Maintains: Buy
Price Target: $52 → $51
Current: $43.76
Upside: +16.54%
Agios Pharmaceuticals
Nov 20, 2025
Maintains: Buy
Price Target: $56 → $48
Current: $27.49
Upside: +74.61%
Olema Pharmaceuticals
Nov 18, 2025
Maintains: Buy
Price Target: $28 → $36
Current: $27.25
Upside: +32.11%
Artiva Biotherapeutics
Nov 12, 2025
Maintains: Buy
Price Target: $12 → $15
Current: $3.58
Upside: +318.99%
Sana Biotechnology
Nov 7, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $4.47
Upside: +101.34%
Context Therapeutics
Nov 6, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $1.09
Upside: +358.72%
Ventyx Biosciences
Nov 5, 2025
Upgrades: Buy
Price Target: $18
Current: $7.84
Upside: +129.59%
NovoCure
Oct 30, 2025
Maintains: Buy
Price Target: $38 → $42
Current: $11.81
Upside: +255.63%
Arcus Biosciences
Oct 29, 2025
Maintains: Buy
Price Target: $24 → $28
Current: $25.63
Upside: +9.25%
Oct 27, 2025
Maintains: Buy
Price Target: $27 → $72
Current: $32.06
Upside: +124.61%
Oct 14, 2025
Initiates: Buy
Price Target: $12
Current: $2.20
Upside: +445.45%
Oct 6, 2025
Assumes: Buy
Price Target: $60
Current: $31.61
Upside: +89.81%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.64
Upside: -
Sep 10, 2025
Reiterates: Buy
Price Target: $23
Current: $4.17
Upside: +451.56%
Aug 27, 2025
Maintains: Buy
Price Target: $32 → $40
Current: $12.64
Upside: +216.46%
Aug 15, 2025
Upgrades: Buy
Price Target: $35
Current: $10.93
Upside: +220.22%
Aug 13, 2025
Reiterates: Buy
Price Target: $36
Current: $25.86
Upside: +39.21%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $0.89
Upside: +800.09%
Jul 22, 2025
Maintains: Buy
Price Target: $10 → $9
Current: $3.71
Upside: +142.78%
Jul 7, 2025
Maintains: Buy
Price Target: $40 → $20
Current: $1.65
Upside: +1,112.12%
Jul 1, 2025
Reiterates: Buy
Price Target: $36
Current: $12.04
Upside: +199.13%
Jun 16, 2025
Reiterates: Buy
Price Target: $115
Current: $72.94
Upside: +57.66%
Apr 16, 2025
Maintains: Buy
Price Target: $560 → $280
Current: $8.41
Upside: +3,229.37%
Apr 1, 2025
Reiterates: Buy
Price Target: $8
Current: $2.65
Upside: +201.89%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $4.65
Upside: +545.16%
Mar 27, 2025
Reiterates: Buy
Price Target: $18
Current: $1.78
Upside: +911.24%
Mar 26, 2025
Reiterates: Buy
Price Target: $183
Current: $3.96
Upside: +4,517.19%
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $0.74
Upside: +847.87%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.27
Upside: -
Feb 3, 2025
Reiterates: Buy
Price Target: $18
Current: $1.33
Upside: +1,253.38%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $0.78
Upside: +4,105.43%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.54
Upside: -